Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly
By Jen Christensen, CNN (CNN) — The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration has approved a new monoclonal antibody to help prevent infection, according to an announcement late Monday from
Continue Reading